Chinese Cardiologists' Knowledge/Practices on Flu Vaccine for Chronic Coronary Syndrome
NCT ID: NCT06991088
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
5000 participants
OBSERVATIONAL
2025-06-30
2027-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cohort Study of Chronic Heart Failure
NCT05960890
Cohort Study of Chronic Heart Failure
NCT06092658
Clinical Characteristics and Outcomes of Coronary Heart Disease
NCT06335901
Flu Vaccination in Congestive Heart Failure
NCT00664339
Implementing a Digitally-enabled Community Health Worker Intervention for Patients With Heart Failure
NCT05130008
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chief Physician (Professor-level)
Responses from chief physicians (professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.
No interventions assigned to this group
Associate Chief Physician (Associate Professor-level)
Responses from Associate Chief Physician (Associate Professor-level) across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.
No interventions assigned to this group
Attending Physician
Responses from Attending Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.
No interventions assigned to this group
Resident Physician
Responses from chief Resident Physician across various regions, age groups, hospital types, and years of practice in China were collected via questionnaire survey. The study assessed their knowledge level regarding influenza vaccine application in CCS patients, investigated their perceptions on whether vaccination benefits patients' health outcomes, evaluated current vaccination implementation practices, and determined their support for influenza immunization.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Physicians unable to complete the questionnaire survey.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Affiliated Hospital of Hangzhou Normal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MingWei Wang
Hanzhou, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AH-2025-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.